Skip to main content
. 2015 Jun 15;5(7):2202–2211.

Figure 4.

Figure 4

Cell viability (A) and apoptosis (B) of HCC827-ER cells treated with DMEM (I), Erlotinib (II), U0126+MK-2206 (III), Erlotinib+U0126+MK-2206 (IV), Erlotinib+VPA (V) assessed by MTT and apoptosis assay, respectively. (*P > 0.05 vs I or II; *P < 0.05 vs IV or V; †P < 0.05 vs III or V).